Reem Hal/LinkedIn
Dec 25, 2025, 23:39
Reem Hal Shares New Clinical Capsule: Thrombosis in Cancer Patients
Reem Hal, Senior Pediatric Oncology Clinical Pharmacist at Borg El Arab Main University Hospital, shared a post on LinkedIn:
“Clinical Capsule | Oncology Rounds
Capsule #5 – Thrombosis in Cancer Patients
‘The cancer didn’t cause the ICU admission — the missed prophylaxis did.’
A patient with multiple myeloma on
lenalidomide + dexamethasone
missed thromboprophylaxis →
acute myocardial infarction. ICU admission.
Clinical Pearl
IMiD-based regimens dramatically increase thrombotic risk.
Standard practice
- Low risk → Aspirin
- High risk → LMWH or DOAC
Missed prophylaxis may lead to
- MI or stroke
- Treatment interruption
Take-home message
In multiple myeloma, thromboprophylaxis is not optional — it is life-saving.”
Follow the latest in Hemostasis Today.
-
Apr 8, 2026, 16:16Hans Middelhoven: HARMONICS – Improving Stroke Care Outcomes in Spain and Portugal
-
Apr 8, 2026, 16:16Tiffany Hall: HerCare – the Ultimate ‘BOGO’ in Maternal Health
-
Apr 8, 2026, 16:14Haroun Gajraj: UGFS as a Minimally Invasive and Safe Option for Superficial Venous Thrombosis
-
Apr 8, 2026, 16:13Lama Samia: Biochemical Cascade of Myocardial Infarction
-
Apr 8, 2026, 16:07Nathan Connell: Advancing Systems – Based Hematology
-
Apr 8, 2026, 15:51Veronica Sanchez: 5 Tips for Accurate Home Blood Pressure Readings
-
Apr 8, 2026, 15:40Heghine Khachatryan: How Blood Tests Help Manage Antiphospholipid Syndrome in Pregnancy
-
Apr 8, 2026, 15:21Nathan Connell: Persistent Gaps in Hemophilia A Care Despite Prophylaxis
-
Apr 8, 2026, 15:16Avril Mansfield: Why Aren’t More Stroke Patients Meeting Aerobic Exercise Guidelines?